Evidence map›Paper›PMID 39997467›Full record

ReviewInfectious disease reports2025

Genetics of Long COVID: Exploring the Molecular Drivers of Persistent Pulmonary Vascular Disease Symptoms.

Sana Ayyoub, Navneet Kaur Dhillon, Olga Tura-Ceide

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Infectious disease reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. COVID-19: a vascular nightmare unfolding.Frontiers in immunology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sana AyyoubDepartment of Medical Sciences, Faculty of Medicine, University of Girona, 17004 Girona, Spain.
Navneet Kaur DhillonDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Kansas Medical Center, Mail Stop 3007, 3901 Rainbow Blvd, Kansas City, KS 66160, USA.
Olga Tura-CeideTranslational Research Group on Cardiovascular Respiratory Diseases (CAREs), Girona Biomedical Research Institute (IDIBGI-CERCA), Martí i Julià, Hospital Park Building M2, 17190 Salt, Spain.ORCID 0000-0003-4334-9790

Funding

Drug abuse and HIV-associated pulmonary vascular injuryR01HL152832 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DHILLON, NAVNEET KAUR · 2021 to 2024
$2.8M
AGAUR-FI ajuts Joan Oró, backed by the Secretariat of Universities and Research of the Department of Research and Universities of the Generalitat of Catalonia, and the European Social Plus Fund 2024 FI-3 00065Catalan Pneumology Foundation (FUCAP) and from the Institute of Health Carlos III PI21/01212Miguel Servet type grants from the Institute of Health Carlos III CP17/00114, CPII22/00006)NHLBI NIH HHS R01 HL152832NIH Funding R01HL1528322
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

endothelial dysfunctiongenetic polymorphismlong COVIDpulmonary disorderpulmonary hypertensionSARS-CoV-2thrombosis

Identifiers

PMID39997467
PMCPMC11855385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.